3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
23
Active not recruiting
7
Recruiting
6
Terminated
5
Withdrawn
2
Unknown
2
Suspended
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
17
Stomach Neoplasms
14
Rectal Neoplasms
10
Pancreatic Neoplasms
7
Colonic Neoplasms
6
Biliary Tract Neoplasms
5
Adenocarcinoma
4
HER2-positive Gastric Cancer
3
Esophageal Neoplasms
3
Cholangiocarcinoma
3
Ovarian Neoplasms
2
Neoplasms
2
Lymphoma, Extranodal NK-T-Cell
2
Locally Advanced Gastric Cancer
2
Cirrhosis, Familial, with Pulmonary Hypertension
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Spinocerebellar Degenerations
1
Rectal Neoplasms Malignant
1
Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer
1
Pathologic Complete Response
1
Pancreatic Cancer Resectable
1
PDAC - Pancreatic Ductal Adenocarcinoma
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Neoadjuvant Chemotherapy
1
MSI-H Colorectal Cancer
1
Locally Advanced Rectal Cancer (LARC)
1
Locally Advanced Rectal Cancer
1
Locally Advanced Low Rectal Adenocarcinoma
1
Interventions
Specimen Handling
2
Endoscopy
2
tremelimumab
1
futibatinib
1
durvalumab
1
Taxes
1
Risk Assessment
1
Ramucirumab
1
Radiofrequency Ablation
1
Paclitaxel
1
Oxaliplatin
1
Observation
1
Mass Screening
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
Itraconazole
1
Folfox protocol
1
Fluorouracil
1
Breath Tests
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Adenocarcinoma Of Esophagus
×
Oxaliplatin
×
Clear all
NCT07603375
2026-05-29
TNT Esophagus
Duke University
Phase 2
Not yet recruiting
60 enrolled